Objects
Stewart, Tamasine, Spelman, Tim, Grand'Maison, Francois, Grammond, Pierre, Sola, Patrizia, Shaygannejad, Vahid, Hupperts, Raymond, Alroughani, Raed, Oreja-Guevara, Celia, Pucci, Eugenio, Boz, Cavit, Lechner-Scott, Jeannette, Havrdova, Eva, , , , , , , , , , , Horakova, Dana, , , , , , , , , , , Trojano, Maria, , , , , , , , , , , Izquierdo, Guillermo, , , , , , Duquette, Pierre, Girard, Marc, Prat, Alexandre, Lugaresi, Alessandra. Sage; 2017. Contribution of different relapse phenotypes to disability in multiple sclerosis.
He, Anna, Spelman, Tim, Girard, Marc, Pucci, Eugenio, Iuliano, Gerardo, Alroughani, Raed, Oreja-Guevara, Cekia, Fernandez-Bolaños, Ricardo, Grand'Maison, Francois, Sola, Patrizia, Spitaleri, Daniele, Granella, Franco, Jokubaitis, Vilijia, Lechner-Scott, Jeannette, , , , , , , , , , Havrdova, Eva, , Horakova, Dana, Trojano, Maria, Lugaresi, Alessandra, Izquierdo, Guillermo, Grammond, Pierre, Duquette, Pierre. American Medical Association; 2015. Comparison of switch to fingolimod or interferon beta/glatiramer acetate in active multiple sclerosis.
Jokubaitis, Vilija G., Li, Vivien, Barnett, Michael, Grand'Maison, Francois, Trojano, Maria, Slee, Mark, Giuliani, Giorgio, Shaw, Cameron, Boz, Cavit, Spitaleri, Daniele L. A., Verheul, Freek, Haartsen, Jodi, Kalincik, Tomas, Liew, Danny, Butzkueven, Helmut, Izquierdo, Guillermo, Hodgkinson, Suzanne, Alroughani, Raed, Lechner-Scott, Jeannette, Lugaresi, Alessandra, Duquette, Pierre, Girard, Marc. Lippincott Williams & Wilkins; 2014. Fingolimod after natalizumab and the risk of short-term relapse.
Maltby, Vicki E., Lea, Rodney A., Graves, Moira C., Sanders, Katherine A., Benton, Miles C., Tajouri, Lotti, Scott, Rodney J., Lechner-Scott, Jeannette. Nature Publishing Group; 2018. Genome-wide DNA methylation changes in CD19⁺ B cells from relapsing-remitting multiple sclerosis patients.
Meyniel, Claire, Spelman, Timothy, Grammond, Pierre, Iuliano, Gerardo, Fiol, Marcela, Cabrera-Gomez, Jose Antonio, Fernandez-Bolanos, Ricardo, Giuliani, Giorgio, Lechner-Scott, Jeannette, Cristiano, Edgardo, Herbert, Joseph, Petkovska-Boskova, Tatjana, Jokubaitis, Vilija G., Trojano, Maria, Izquierdo, Guillermo, Grand’Maison, François, Oreja-Guevara, Celia, Boz, Cavit, Lugaresi, Alessandra, Girard, Marc. Public Library of Science; 2012. Country, sex, EDSS change and therapy choice independently predict treatment discontinuation in multiple sclerosis and clinically isolated syndrome.
Burnard, Sean, Lechner-Scott, Jeannette, Scott, Rodney J.. Elsevier; 2017. EBV and MS: major cause, minor contribution or red-herring?.
Kalincik, Tomas, Horakova, Dana, Duquette, Pierre, Girard, Marc, Pucci, Eugenio, Lechner-Scott, Jeannette, Slee, Mark, Fernandez-Bolanos, Ricardo, Grand'Maison, Francois, Hupperts, Raymond, Verheul, Freek, Hodgkinson, Suzanne, Spelman, Tim, , , , , , , , , , , Jokubaitis, Vilijia, , , , Trojano, Maria, Lugaresi, Alessandra, Izquierdo, Guillermo, Rozsa, Csilla, Grammond, Pierre, Alroughani, Raed. John Wiley & Sons; 2015. Switch to natalizumab versus fingolimod in active relapsing-remitting multiple sclerosis.
Trojano, Maria, Lucchese, Guglielmo, Bergamaschi, Roberto, Giuliani, Giorgio, Boz, Cavit, Hupperts, Raymond, Van Pesch, Vincent, Lechner-Scott, Jeannette, Cristiano, Edgardo, Fiol, Marcela, Oreja-Guevara, Celia, Saladino, Maria Laura, Taylor, Bruce V., Simpson, Steve, Lepore, Vito, Grand’Maison, Francois, Duquette, Pierre, Izquierdo, Guillermo, Grammond, Pierre, Amato, Maria Pia. Public Library of Science; 2012. Geographical variations in sex ratio trends over time in multiple sclerosis.
Kalincik, Tomas, Jokubaitis, Vilija, Grand'Maison, Francois, Pucci, Eugenio, Van Pesch, Vincent, Boz, Cavit, Iuliano, Gerardo, Fernandez-Bolanos, Ricardo, Flechter, Shlomo, Spitaleri, Daniele, Cristiano, Edgardo, Verheul, Ferek, Izquierdo, Guillermo, Lechner-Scott, Jeannette, Amato, Maria Pia, Cabrera-Gomez, Jose Antonio, Saladino, Maria Laura, Slee, Mark, Moore, Fraser, Gray, Orla, Paine, Mark, Barnett, Michael, Havrdova, Eva, Duquette, Pierre, Horakova, Dana, Spelman, Timothy, Trojano, Maria, Butzkueven, Helmut, , , Girard, Marc, Grammond, Pierre, Lugaresi, Alessandra, Oreja-Guevara, Celia, Bergamaschi, Roberto, Hupperts, Raymond. Sage; 2014. Comparative effectiveness of glatiramer acetate and interferon beta formulations in relapsing-remitting multiple sclerosis.
Odenthal, Cara, Simpson Jr, Steve, Coulthard, Alan, Ausimmune AusLong Investigator Groups,, Williams, David, Lechner-Scott, Jeannette, , , , , , , Oughton, Justin, , , van der Mei, Ingrid, Rose, Stephen, Fripp, Jurgen, Lucas, Robyn, Taylor, Bruce, Dear, Keith, Ponsonby, Anne-Louise. Wiley-Blackwell; 2017. Midsagittal corpus callosum area and conversion to multiple sclerosis after clinically isolated syndrome: a multicentre Australian cohort study.
Cox, Mathew B., Bowden, Nikola A., Scott, Rodney J., Lechner-Scott, Jeannette. Sage; 2013. Altered expression of the plasminogen activation pathway in peripheral blood mononuclear cells in multiple sclerosis: possible pathomechanism of matrix metalloproteinase activation.
Cox, Mathew B., Bowden, Nikola A., Scott, Rodney J., Lechner-Scott, Jeannette. Sage; 2014. Common genetic variants in the plasminogen activation pathway are not associated with multiple sclerosis.
Cox, Mathew B., Ban, Maria, Bowden, Nikola A., Baker, Amie, Scott, Rodney J., Lechner-Scott, Jeannette. Sage; 2012. Potential association of vitamin D receptor polymorphism Taq1 with multiple sclerosis.
Bahlo, Melanie, Booth, David R., Rubio, Justin P., Scott, Rodney J., Stankovich, Jim, Stewart, Graeme J., Taylor, Bruce V., Wiley, James, Clarke, Glynnis, Cox, Mathew B., Csurhes, Peter A., Danoy, Patrick, Broadley, Simon A., Brown, Matthew A., Foote, Simon J., Griffiths, Lyn R., Kilpatrick, Trevor J., Lechner-Scott, Jeannette, Moscato, Pablo, Perreau, Victoria M.. Nature Publishing Group; 2009. Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20.
Pan, Gongbu, Simpson, Steve, Williams, David, Lechner-Scott, Jeannette, Van Der Mei, Ingrid, Charlesworth, Jac C., Lucas, Robyn, Ponsonby, Anne-Louise, Zhou, Yuan, Taylor, Bruce V.. BMJ Group; 2016. Role of genetic susceptibility variants in predicting clinical course in multiple sclerosis: a cohort study.
Cortes, Adrian, Field, Judith, Glazov, Evgeny A., Hadler, Johanna, ANZgene Consortium,, Stankovich, Jim, Brown, Matthew A., Lechner-Scott, Jeannette, Moscato, Pablo. Oxford University Press; 2013. Resequencing and fine-mapping of the chromosome 12q13-14 locus associated with multiple sclerosis refines the number of implicated genes.
Broadley, Simon A., Barnett, Michael H., Marriott, Mark, Mason, Deborah F., Parratt, John, Reddel, Stephen W., Shaw, Cameron P., Slee, Mark, Spies, Judith, Taylor, Bruce V., Carroll, William M., Kilpatrick, Trevor J., Boggild, Mike, King, John, McCombe, Pamela A., Pollard, John D., Willoughby, Ernest, Brew, Bruce J., Butzkueven, Helmut, Heard, Robert, Hodgkinson, Suzanne, Kermode, Allan G., Lechner-Scott, Jeannette, Macdonell, Richard A. L.. Elsevier; 2014. Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 1 Historical and established therapies.
Maltby, Vicki E., Lea, Rodney A., Sanders, Katherine A., White, Nicole, Benton, Miles C., Scott, Rodney J., Lechner-Scott, Jeannette. BioMed Central; 2017. Differential methylation at MHC in CD4⁺ T cells is associated with multiple sclerosis independently of HLA-DRB1.
Patsopoulos, Nikolaos A., de Bakker, Paul I. W., Kappos, Ludwig, Miller, David, Montalbán, Javier, Polman, Chris H., Freedman, Mark S., Hartung, Hans-Peter, Arnason, Barry G. W., Comi, Giancarlo, Cook, Stuart, Filippi, Massimo, Esposito, Federica, Goodin, Douglas S., Jeffery, Douglas, O'Connor, Paul, Ebers, George C., Langdon, Dawn, Reder, Anthony T., Traboulsee, Anthony, Zipp, Frauke, Schimrigk, Sebastian, Hillert, Jan, Reischl, Joachim, Bahlo, Melanie, Booth, David R., Broadley, Simon, Brown, Matthew A., Browning, Brian L., Browning, Sharon R., Butzkueven, Helmut, Carroll, William M., Chapman, Caron, Foote, Simon J., Lehr, Stephan, Griffiths, Lyn, Kermode, Allan G., Kilpatrick, Trevor J., Lechner-Scott, Jeannette, Marriott, Mark, Mason, Deborah, Moscato, Pablo, Heard, Robert N., Pender, Michael P., Perreau, Victoria M., Bauer, David, Perera, Devindri, Rubio, Justin P., Scott, Rodney J., Slee, Mark, Stankovich, Jim, Stewart, Graeme J., Taylor, Bruce V., Tubridy, Niall, Willoughby, Ernest, Wiley, James, Heubach, Jürgen, Matthews, Paul, Boneschi, Filippo M., Compston, Alastair, Haines, Jonathan, Hauser, Stephen L., McCauley, Jacob, Ivinson, Adrian, Oksenberg, Jorge R., Pericak-Vance, Margaret, Sawcer, Stephen J., Sandbrink, Rupert, De Jager, Philip L., Hafler, David A., Pohl, Christoph, Edan, Gilles. John Wiley & Sons; 2011. Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci.
Field, Judith, Shahijanian, Fernando, Butzkueven, Helmut, Booth, David, Baxter, Alan, Kermode, Allan G., Taylor, Bruce, Booth, David R., Mason, Deborah, Stewart, Graeme J., Butzkueven, Helmut, Charlesworth, Jac, Schibeci, Stephen, Wiley, James, Lechner-Scott, Jeannette, Field, Judith, Tajouri, Lotti, Griffiths, Lyn, Slee, Mark, Brown, Matthew A., Moscato, Pablo, Scott, Rodney J., Broadley, Simon, Johnson, Laura, Vucic, Steve, Kilpatrick, Trevor, Carroll, William M., Gresle, Melissa, Laverick, Louise, Parnell, Grant, Stewart, Graeme, McKay, Fiona, Kilpatrick, Trevor. Public Library of Science (PLOS); 2015. The MS risk allele of CD40 is associated with reduced cell-membrane bound expression in antigen presenting cells: implications for gene function.
Yan, Jun, Liu, Jia, Mason, Deborah, Griffiths, Lyn, Moscato, Pablo, Slee, Mark, Taylor, Bruce, Wiley, James, Field, Judith, Butzkueven, Helmut, Kilpatrick, Trevor J., Csurhes, Peter A., Lin, Clement Yihao, Pender, Michael P., McCombe, Pamela A., Greer, Judith M., Australia and New Zealand Multiple Sclerosis Genetics Consortium (ANZGene),, Scott, Rodney J., Lechner-Scott, Jeannette, Brown, Matthew A., Booth, David R., Stewart, Graeme J., Broadley, Simon. MDPIAG; 2012. Interleukin-6 gene promoter-572 C allele may play a role in rate of disease progression in multiple sclerosis.
Lizak, Nathaniel, Lugaresi, Alessandra, Girard, Marc, Prat, Alexandre, Grammond, Pierre, Hupperts, Raymond, Grand'Maison, Francois, Sola, Patrizia, Pucci, Eugenio, Bergamaschi, Roberto, Oreja-Guevara, Celia, Van Pesch, Vincent, Alroughani, Raed, , , , , , , , , , , Lechner-Scott, Jeannette, , , , , , , , Slee, Mark, Havrdova, Eva, Horakova, Dana, Trojano, Maria, Izquierdo, Guillermo, Duquette, Pierre. BMJ Group; 2017. Highly active immunomodulatory therapy ameliorates accumulation of disability in moderately advanced and advanced multiple sclerosis.
Kister, Ilya, Chamot, Eric, Duquette, Pierre, Lugaresi, Alessandra, Grammond, Pierre, Boz, Cavit, Hupperts, Raymond, Petersen, Thor, Giuliani, Giorgio, Oreja-Guevara, Celia, Iuliano, Gerardo, Lechner-Scott, Jeannette, Cutter, Gary, , , , , , , , , , Bacon, Tamar E., Jokubaitis, Vilija G., Hughes, Stella E., Gray, Orla M., Trojano, Maria, Izquierdo, Guillermo, Grand'Maison, Francois. Elsevier; 2012. Increasing age at disability milestones among MS patients in the MSBase Registry.
Ritchie, Matthew E., Ruijie, Liu, Kilpatrick, Trevor J., Lechner-Scott, Jeannette, Moscato, Pablo, Perreau, Victoria M., Rubio, Justin P., Scott, Rodney J., Stankovich, Jim, Stewart, Graeme J., Taylor, Bruce V., Wiley, James, Carvalho, Benilton S., Booth, David R., Clarke, Glynnis, Cox, Mathew B., Csurhes, Peter A., Danoy, Patrick, Dickinson, Joanne L., Drysdale, Karen, Field, Judith, Greer, Judith M., Griffiths, Lyn R., Irizarry, Rafael A., Guru, Preethi, Hadler, Johanna, Hoban, Ella, McMorran, Brendan J., Jensen, Cathy J., Johnson, Laura J., McCallum, Ruth, Merriman, Marilyn, Merriman, Tony, Polanowski, Andrea, Bahlo, Melanie, Pryce, Karena, Tajouri, Lotfi, Whittock, Lucy, Wilkins, Ella J., Browning, Brian L., Browning, Sharon R., Perera, Devindri, Butzkueven, Helmut, Carroll, William M., Chapman, Caron, Booth, David R., Kermode, Allan G., Marriott, Mark, Mason, Deborah, Heard, Robert N., Pender, Michael P., Slee, Mark, Tubridy, Niall, Willoughby, Ernest, Broadley, Simon A., Brown, Matthew A., Foote, Simon J., Griffiths, Lyn R.. BioMed Central; 2011. Comparing genotyping algorithms for Illumina's Infinium whole-genome SNP BeadChips.
Wang, Joanne H., Pappas, Derek, Hauser, Stephen L., Baranzini, Sergio E., Oksenberg, Jorge R., Bahlo, Melanie, Booth, David R., Broadley, Simon A., Brown, Matthew A., Foote, Simon J., Griffiths, Lyn R., Kilpatrick, Trevor J., De Jager, Philip L., Lechner-Scott, Jeannette, Moscato, Pablo, Perreau, Victoria M., Rubio, Justin P., Scott, Rodney J., Stankovich, Jim, Stewart, Graeme J., Taylor, Bruce V., Wiley, James, Danoy, Patrick, Pelletier, Daniel, Butzkueven, Helmut, Slee, Mark, Greer, Judith, Kermode, Allan, Carroll, William, de Bakker, Paul I., Kappos, Ludwig, Polman, Chris H., Chibnik, Lori B., Hafler, David A., Matthews, Paul M.. BioMed Central; 2011. Modeling the cumulative genetic risk for multiple sclerosis from genome-wide association data.
Kalincik, Tomas, Brown, J. William L., McGuigan, Christopher, Jokubaitis, Vilija, Spelman, Tim, Horakova, Dana, Havrdova, Eva, Trojano, Maria, Izquierdo, Guillermo, Lugaresi, Alessandra, Prat, Alexandre, Girard, Marc, Robertson, Neil, Lechner-Scott, Jeannette, , , , , , , , , , Willis, Mark, , , , , , , , , , , Scolding, Neil, , , , , , , , , , , Rice, Claire M., Wilkins, Alastair, Pearson, Owen, Ziemssen, Tjalf, Hutchinson, Michael. Lancet Publishing; 2017. Treatment effectiveness of alemtuzumab compared with natalizumab, fingolimod, and interferon beta in relapsing-remitting multiple sclerosis: a cohort study.
Broadley, Simon A., Barnett, Michael H., Marriott, Mark, Mason, Deborah F., Parratt, John, Reddel, Stephen W., Shaw, Cameron P., Slee, Mark, Spies, Judith, Taylor, Bruce V., Carroll, William M., Kilpatrick, Trevor J., Boggild, Mike, King, John, McCombe, Pamela A., Pollard, John D., Willoughby, Ernest, Brew, Bruce J., Butzkueven, Helmut, Heard, Robert, Hodgkinson, Suzanne, Kermode, Allan G., Lechner-Scott, Jeannette, Macdonell, Richard A. L.. Elsevier; 2014. Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 2 New and emerging therapies and their efficacy.
Goris, An, Pauwels, Ine, D'Alfonso, Sandra, Barizzone, Nadia, Leone, Maurizio A., Boneschi, Filippo Martinelli, Sorosina, Melissa, Liberatore, Giuseppe, Kockum, Ingrid, Olsson, Tomas, Hillert, Jan, Alfredsson, Lars, Gustavsen, Marte W., Lechner-Scott, Jeannette, , , , , , , , , , van Son, Brechtje, , , , , , , , , , , Hilven, Kelly, , , , , , , , Bos, Steffan D., Celius, Elisabeth Gulowsen, Berg-Hansen, Pål, Aarseth, Jan, Myhr, Kjell-Morten. Oxford University Press; 2015. Genetic variants are major determinants of CSF antibody levels in multiple sclerosis.
Spelman, Tim, Kalincik, Tomas, Havrdová, Eva, Horáková, Dana, Grammond, Pierre, Duquette, Pierre, Prat, Alexandre, Iuliano, Gerardo, Terzi, Murat, Izquierdo, Guillermo, Hupperts, Raymond M.M., , Jokubaitis, Vilija, , , , , Lechner-Scott, Jeannette, , , , , , Zhang, Annie, , Pellegrini, Fabio, Wiendl, Heinz, Belachew, Shibeshih, Hyde, Robert, Verheul, Freek, Lugaresi, Alessandra. Lippincott Williams & Wilkins; 2016. Comparative efficacy of first-line natalizumab vs IFN-ß or glatiramer acetate in relapsing MS.
Riveros, Carlos, Mellor, Drew, Vucic, Stephen, Stewart, Graeme J., Williams, David W., Scott, Rodney J., Lechner-Scott, Jeannette, Booth, David R., Moscato, Pablo, ANZgene Multiple Sclerosis Genetics Consortium, Gandhi, Kaushal S., McKay, Fiona C., Cox, Mathew B., Berretta, Regina, Vaezpour, S. Yahya, Inostroza-Ponta, Mario, Broadley, Simon A., Heard, Robert N.. Public Library of Science; 2010. A transcription factor map as revealed by a genome-wide gene expression analysis of whole-blood mRNA transcriptome in multiple sclerosis.
Jokubaitis, Vilija G., Spelman, Tim, Cabrera-Gomez, José, Oreja-Guevara, Celia, Boz, Cavit, Giuliani, Giorgio, Fernández-Bolaños, Ricardo, Iuliano, Gerardo, Lechner-Scott, Jeannette, Verheul, Freek, van Pesch, Vincent, Petkovska-Boskova, Tatjana, Kalincik, Tomas, Fiol, Marcela, Moore, Fraser, Cristiano, Edgardo, Alroughani, Raed, Bergamaschi, Roberto, Barnett, Michael, Slee, Mark, Vella, Norbet, Herbert, Joseph, Shaw, Cameron, Izquierdo, Guillermo, Saladino, Maria Laura, Amato, Maria Pia, Liew, Danny, Paolicelli, Damiano, Butzkueven, Helmut, Trojano, Maria, Grand'Maison, François, Duquette, Pierre, Girard, Marc, Lugaresi, Alessandra, Grammond, Pierre, Hupperts, Raymond. John Wiley & Sons; 2015. Predictors of disability worsening in clinically isolated syndrome.
Broadley, Simon A., Barnett, Michael H., Marriott, Mark, Mason, Deborah F., Parratt, John, Reddel, Stephen W., Shaw, Cameron P., Slee, Mark, Spies, Judith M., Taylor, Bruce V., Carroll, William M., Kilpatrick, Trevor J., Boggild, Mike, King, John, McCombe, Pamela A., Pollard, John D., Willoughby, Ernest, Brew, Bruce J., Butzkueven, Helmut, Heard, Robert, Hodgkinson, Suzanne, Kermode, Allan G., Lechner-Scott, Jeannette, Macdonell, Richard A. L.. Australasian Medical Publishing Company Pty. Ltd.; 2015. A new era in the treatment of multiple sclerosis.
Quadrelli, Scott, Ribbons, Karen, Arm, Jameen, Al-iedani, Oun, Lechner-Scott, Jeannette, Lea, Rodney, Ramadan, Saadallah. Sage; 2019. 2D in-vivo L-COSY spectroscopy identifies neurometabolite alterations in treated multiple sclerosis.
Maltby, Vicki E., Graves, Moira C., Lea, Rodney A., Benton, Miles C., Sanders, Katherine A., Tajouri, Lotti, Scott, Rodney J., Lechner-Scott, Jeannette. BioMed Central; 2015. Genome-wide DNA methylation profiling of CD8+T cells shows a distinct epigenetic signature to CD4+T cells in multiple sclerosis patients.
Warrender-Sparkes, Matthew, Spelman, Tim, Alroughani, Raed, Iuliano, Gerardo, Duquette, Pierre, Girard, Marc, Terzi, Murat, Hupperts, Raymond, Grammond, Pierre, Petersen, Thor, Fernandez-Bolaños, Ricardo, Fiol, Marcela, Izquierdo, Guillermo, Lechner-Scott, Jeannette, Trojano, Maria, Lugaresi, Alessandra, Grand'Maison, François, Havrdova, Eva, Horakova, Dana, Boz, Cavit, Oreja-Guevara, Celia. Sage; 2016. The effect of oral immunomodulatory therapy on treatment uptake and persistence in multiple sclerosis.
Kalincik, Tomas, Buzzard, Katherine, Oreja-Guevara, Celia, Boz, Cavit, Hupperts, Raymond, Petersen, Thor, Giuliani, Giorgop, Iuliano, Gerardo, Lechner-Scott, Jeannette, Barnett, Michael, Bergamaschi, Roberto, Van Pesch, Vincent, Jokubaitis, Vilija, Amato, Maria Pia, van Munster, Erik, Fernandez-Bolanos, Ricardo, Verheul, Freek, Fiol, Marcela, Cristiano, Edgardo, Slee, Mark, Rio, Maria Edite, Spitaleri, Daniele, Alroughani, Raed, Trojano, Maria, Gray, Orla, Saladino, Maria Laura, Flechter, Sholmo, Herbert, Joseph, Cabrera-Gomez, Jose Antonio, Vella, Norbert, Paine, Mark, Shaw, Cameron, Moore, Fraser, Vucic, Steve, Duquette, Pierre, Savino, Aldo, Singhal, Bhim, Petkovska-Boskova, Tatjana, Parratt, John, Sirbu, Carmen-Adella, Rozsa, Csilla, Liew, Danny, Butzkueven, Helmut, , Izquierdo, Guillermo, Girard, Marc, Lugaresi, Alessandra, Grammond, Pierre, Grand'Maison, Francois. Sage Publications; 2014. Risk of relapse phenotype recurrence in multiple sclerosis.
Gandhi, Kaushal S., McKay, Fiona C., Danoy, Patrick, Stewart, Graeme J., Broadley, Simon, Moscato, Pablo, Lechner-Scott, Jeannette, Scott, Rodney J., Booth, David R., ANZgene Multiple Sclerosis Genetics Consortium, Cox, Mathew, Riveros, Carlos, Armstrong, Nicola, Heard, Robert N., Vucic, Steve, Williams, David W., Stankovich, Jim, Brown, Matthhew. Oxford University Press; 2010. The multiple sclerosis whole blood mRNA transcriptome and genetic associations indicate dysregulation of specific T cell pathways in pathogenesis.
Bukhari, Wajih, Prain, Kerri M., Blum, Stefan, Boggild, Mike, Boundy, Karyn, Brew, Bruce J., Brown, Matthew, Brownlee, Wallace J., Butzkueven, Helmut, Carroll, William M., Chen, Celia, Coulthard, Alan, Waters, Patrick, Dale, Russell C., Woodhall, Mark, Lechner-Scott, Jeannette, O'Gorman, Cullen M., Clarke, Laura, Silvestrini, Roger A., Bundell, Christine S., Abernethy, David, Bhuta, Sandeep. BMJ Group; 2017. Incidence and prevalence of NMOSD in Australia and New Zealand.
Gu, Ben J., Field, Judith, Butzkueven, Helmut, Gresle, Melissa, Laws, Simon M., Petrou, Steven, Hoffjan, Sabine, Akkad, Denis A., Graham, Colin A., Hawkins, Stanley, Glaser, Anna, Bedri, Sahl Khalid, Dutertre, Sébastien, Hillert, Jan, Matute, Carlos, Antiguedad, Alfredo, Wiley, James S., Ou, Amber, Kilpatrick, Trevor J., Lechner-Scott, Jeannette, Scott, Rodney, Lea, Rodney, Taylor, Bruce V., Stankovich, Jim. Oxford University Press; 2015. A rare P2X7 variant Arg307Gln with absent pore formation function protects against neuroinflammation in multiple sclerosis.
Parnell, Grant P., Gatt, Prudence N., Liddle, Christopher, Slee, Mark, Vucic, Steve, Stewart, Graeme J., Booth, David R., McKay, Fiona C., Schibeci, Stephen, Krupa, Malgorzata, Powell, Joseph E., Visscher, Peter M., Montgomery, Grant W., Lechner-Scott, Jeannette, Broadley, Simon. Sage Publications; 2014. Ribosomal protein S6 mRNA is a biomarker upregulated in multiple sclerosis, downregulated by interferon treatment, and affected by season.
Ribbons, Karen, Lea, Rodney, Tiedeman, Clare, Mackenzie, Laura, Lechner-Scott, Jeannette. Sage; 2017. Ongoing increase in incidence and prevalence of multiple sclerosis in Newcastle, Australia: a 50-year study.
Ribbons, Karen, Lea, Rodney, Schofield, Peter W., Lechner-Scott, Jeannette. American Psychiatric Publishing; 2017. Anxiety levels are independently associated with cognitive performance in an Australian multiple sclerosis patient cohort.
Al-iedani, Oun, Lechner-Scott, Jeannette, Ribbons, Karen, Ramadan, Saadallah. BioMed Central; 2017. Fast magnetic resonance spectroscopic imaging techniques in human brain-applications in multiple sclerosis.
Ribbons, Karen Ann, McElduff, Patrick, Oreja-Guevara, Celia, Petersen, Thor, Bergamaschi, Roberto, Giuliani, Giorgio, Barnett, Michael, van Pesch, Vincent, Amato, Maria-Pia, Iuliano, Gerardo, Fiol, Marcela, Slee, Mark, Boz, Cavit, Verheul, Freek, Cristiano, Edgardo, Fernandez-Bolanos, Ricardo, Saladino, Maria-Laura, Rio, Maria Edite, Cabrera-Gomez, Jose, Butzkueven, Helmut, van Munster, Erik, Braber-Moerland, Leontien Den, Spitaleri, Daniele La, Trojano, Maria, Lugaresi, Alessandra, Shaygannejad, Vahid, Gray, Orla, Deri, Norma, Alroughani, Raed, Lechner-Scott, Jeannette, Izquierdo, Guillermo, Duquette, Pierre, Girard, Marc, Grand'Maison, Francois, Hupperts, Raymond, Grammond, Pierre. Public Library of Science (PLoS); 2015. Male sex is independently associated with faster disability accumulation in relapse-onset MS but not in primary progressive MS.
Kalincik, Tomas, Vivek, Vino, Bergamaschi, Roberto, Iuliano, Gerardo, Alroughani, Raed, Van Pesch, Vincent, Amato, Maria Pia, Slee, Mark, Verheul, Freek, Fernandez-Bolanos, Ricardo, Fiol, Marcela, La Spitaleri, Daniele, Jokubaitis, Vilija, , , , , , , , , , , Lechner-Scott, Jeannette, , , , , , , , , , , Trojano, Maria, , , , , , , , , , Izquierdo, Guillermo, Lugaresi, Alessandra, Grand’Maison, Francois, Hupperts, Raymond, Oreja-Guevara, Celia. Oxford University Press; 2013. Sex as a determinant of relapse incidence and progressive course of multiple sclerosis.
Ma, Gerry Z. M., Stankovich, Jim, Browning, Sharon R., Butzkueven, Helmut, Carroll, William M., Danoy, Patrick, Foote, Simon J., Griffiths, Lyn, Heard, Robert N., Kermode, Allan G., Lechner-Scott, Jeannette, Moscato, Pablo, Kilpatrick, Trevor J., Perreau, Victoria M., Scott, Rodney J., Slee, Mark, Stewart, Graeme J., Taylor, Bruce V., Wiley, James, Stankovich, Jim, Binder, Michele D., Field, Judith, Bahlo, Melanie, Booth, David R., Broadley, Simon, Brown, Matthew A., Browning, Brian L.. Public Library of Science; 2011. Polymorphisms in the receptor tyrosine kinase MERTK gene are associated with multiple sclerosis susceptibility.
Groen, Kira, Maltby, Vicki E., Lea, Rodney A., Sanders, Katherine A., Fink, J. Lynn, Scott, Rodney J., Tajouri, Lotti, Lechner-Scott, Jeannette. BioMed Central; 2018. Erythrocyte microRNA sequencing reveals differential expression in relapsing-remitting multiple sclerosis.
Collins, Christian D. E., Ivry, Ben, Bowen, James D., Cheng, Eric M., Dobson, Ruth, Goodin, Douglas S., Lechner-Scott, Jeannette, Kappos, Ludwig, Galea, Ian. Sage; 2015. A comparative analysis of patient-reported expanded disability status scale tools.
Tao, Chunrong, Simpson, Steve, Duquette, Pierre, Girard, Marc, Grand'Maison, Francois, Grammond, Pierre, Alroughani, Raed, Terzi, Murat, Oreja-Guevara, Celia, Sajedi, Seyed Aidin, Iuliano, Gerardo, Sola, Patrizia, van der Mei, Ingrid, Lechner-Scott, Jeannette, Van Pesch, Vincent, Pucci, Eugenio, Bergamaschi, Roberto, Barnett, Michael, Ramo, Cristina, Singhal, Bhim, Spitaleri, Daniele L. A., Slee, Mark, Verheul, Freek, Blizzard, Leigh, Fernández Bolaños, Ricardo, Amato, Maria Pia, Cristiano, Edgardo, Granella, Franco, Hodgkinson, Suzanne, Fiol, Marcela, Gray, Orla, McCombe, Pamela, Saladino, Maria Laura, Sánchez Menoyo, José Luis, Havrdova, Eva, Shuey, Neil, Vucic, Steve, Shaw, Cameron, Deri, Norma, Arruda, Walter Oleschko, Butzkueven, Helmut, Spelman, Tim, Taylor, Bruce V., Horakova, Dana, Shaygannejad, Vahid, Lugaresi, Alessandra, Izquierdo, Guillermo, Trojano, Maria. BMJ Group; 2016. Higher latitude is significantly associated with an earlier age of disease onset in multiple sclerosis.
Kalincik, Tomas, Spelman, Timothy, Grand’Maison, Francois, La Spitaleri, Daniele, Rio, Maria Edite, Flechter, Sholmo, Oreja-Guevara, Celia, Giuliani, Giorgio, Savino, Aldo, Amato, Maria Pia, Petersen, Thor, Fernandez-Bolanos, Ricardo, Trojano, Maria, Bergamaschi, Roberto, Iuliano, Gerardo, Boz, Cavit, Lechner-Scott, Jeannette, Duquette, Pierre, Izquierdo, Guillermo, Grammond, Pierre, Lugaresi, Alessandra, Hupperts, Raymond, Cristiano, Edgardo, Van Pesch, Vincent. Public Library of Science; 2013. Persistence on therapy and propensity matched outcome comparison of two subcutaneous interferon Beta 1a dosages for multiple sclerosis.
Hughes, Stella, Spelman, Timothy, Hupperts, Raymond, Boz, Cavit, Bergamaschi, Roberto, Giuliani, Giorgio, Rio, Maria Edite, Lechner-Scott, Jeannette, Van Pesch, Vincent, Iuliano, Gerardo, Fiol, Marcela, Verheul, Freek, Trojano, Maria, , , , , , , , , , , Lugaresi, Alessandra, , , , , Izquierdo, Guillermo, Grand'Maison, Francois, Duquette, Pierre, Girard, Marc, Grammond, Pierre, Oreja-Guevara, Celia. BMJ Group; 2012. The Kurtzke EDSS rank stability increases 4 years after the onset of multiple sclerosis: results from the MSBase Registry.
Bustamante, Marta F., Morcillo-Suárez, Carlos, Sánchez, Antonio J., Urcelay, Elena, Alvarez-Lafuente, Roberto, Villar, Lusia M., Alvarez-Cermeño, Jose Carlos, Farré, Xavier, Lechner-Scott, Jeannette, Vandenbroeck, Koen, Rodríguez-Antigüedad, Alfredo, Drulovic, Jelena S., Malhotra, Sunny, Martinelli Boneschi, Filippo, Chan, Andrew, Oksenberg, Jorge, Navarro, Arcadi, Montalban, Xavier, Comabella, Manuel, Rio, Jordi, Leyva, Laura, Fernández, Oscar, Zettl, Uwe K., Killestein, Joep, Brassat, David, García-Merino, Juan Antonio. Wolters Klumer Health; 2015. Pharmacogenomic study in patients with multiple sclerosis: responders and nonresponders to IFN-ß.
Sanders, Katherine A., Benton, Miles C., Lea, Rod A., Maltby, Vicki E., Agland, Susan, Griffin, Nathan, Scott, Rodney J., Tajouri, Lotto, Lechner-Scott, Jeannette. BioMed Central; 2016. Next-generation sequencing reveals broad down-regulation of microRNAs in secondary progressive multiple sclerosis CD4+T cells.
Cox, Mathew B., Cairns, Murray J., ANZgene Multiple Sclerosis Genetics Consortium, Gandhi, Kaushal S., Carroll, Adam P., Moscovis, Sophia, Stewart, Graeme J., Broadley, Simon, Scott, Rodney J., Booth, David R., Lechner-Scott, Jeannette. Public Library of Science; 2010. MicroRNAs miR-17 and miR-20a inhibit T cell activation genes and are under-expressed in MS whole blood.
Kalincik, Thomas, Cutter, Gary, Prat, Alexandre, Lugaresi, Alessandra, Grand'Maison, Francois, Grammond, Pierre, Hupperts, Raymond, Oreja-Guevara, Celia, Boz, Cavit, Pucci, Eugenio, Bergamaschi, Roberto, Lechner-Scott, Jeannette, Spelman, Tim, Alroughani, Raed, Van Pesch, Vincent, Iuliano, Gerardo, Fernandez-Bolaños, Ricardo, Ramo, Cristina, Terzi, Murat, Slee, Mark, Spitaleri, Daniele, Verheul, Freek, Cristiano, Edgardo, Jokubaitis, Vilija, Sánchez-Menoyo, José Luis, Fiol, Marcela, Gray, Orla, Cabrera-Gomez, Jose Antonio, Barnett, Michael, Butzkueven, Helmut, Havrdova, Eva, Horakova, Dana, Trojano, Maria, Izquierdo, Guillermo, Girard, Marc, Duquette, Pierre. Oxford University Press; 2015. Defining reliable disability outcomes in multiple sclerosis.
Kalincik, Tomas, Manouchehrinia, Ali, Girard, Marc, Prat, Alexandre, Duquette, Pierre, Grammond, Pierre, Sola, Patrizia, Hupperts, Raymond, Grand'Maison, Francois, Pucci, Eugenio, Boz, Cavit, Alroughani, Raed, Sobisek, Lukas, Lechner-Scott, Jeannette, , , , , , , , , , Jokubaitis, Vilija, , , , , , , , , , , Spelman, Tim, , , , , , , , Horakova, Dana, Havrdova, Eva, Trojano, Maria, Izquierdo, Guillermo, Lugaresi, Alessandra. Oxford University Press; 2017. Towards personalized therapy for multiple sclerosis: prediction of individual treatment response.
Hughes, Stella E., Spelman, Tim, Grammond, Pierre, Oreja-Guevara, Celia, Hupperts, Raymond, Bergamaschi, Roberto, Giuliani, Giorgio, Lechner-Scott, Jeannette, Barnett, Michael, Edite Rio, Maria, Van Pesch, Vincent, Amato, Maria Pia, Gray, Orla M., Iuliano, Gerardo, Slee, Mark, Verheul, Freek, Cristiano, Edgardo, Fernández-Bolaños, Ricardo, Poehlau, Dieter, Saladino, Maria Laura, Deri, Norma, Cabrera-Gomez, Jose, Vella, Norbert, Boz, Cavit, Herbert, Joseph, Skromne, Eli, Savino, Aldo, Shaw, Cameron, Moore, Fraser, Vucic, Steve, Petkovska-Boskova, Tatjana, McDonnell, Gavin, Hawkins, Stanley, Kee, Frank, Trojano, Maria, Butzkueven, Helmut, Lugaresi, Alessandra, Izquierdo, Guillermo, Duquette, Pierre, Girard, Marc, Grand'Maison, Francois. Sage; 2014. Predictors and dynamics of postpartum relapses in women with multiple sclerosis.
Bateman, Grant A., Lechner-Scott, Jeannette, Copping, Ross, Moeskops, Christopher, Yap, Swee Leong. BioMed Central; 2017. Comparison of the sagittal sinus cross-sectional area between patients with multiple sclerosis, hydrocephalus, intracranial hypertension and spontaneous intracranial hypotension: a surrogate marker of venous transmural pressure?.
Jokubaitis, Vilija G., Spelman, Tim, Grammond, Pierre, Van Pesch, Vincent, Pucci, Eugenio, Grand'Maison, François, Hupperts, Raymond, Granella, Franco, Sola, Patrizia, Bergamaschi, Roberto, Iuliano, Gerardo, Spitaleri, Daniele, Kalincik, Tomas, Lechner-Scott, Jeannette, Lorscheider, Johannes, Havrdova, Eva, Horakova, Dana, Duquette, Pierre, Girard, Marc, Prat, Alexandre, Izquierdo, Guillermo. John Wiley & Sons; 2016. Predictors of long-term disability accrual in relapse-onset multiple sclerosis.
Groen, Kira, Maltby, Vicki E., Sanders, Katherine A., Scott, Rodney J., Tajouri, Lotti, Lechner-Scott, Jeannette. Sage; 2016. Erythrocytes in multiple sclerosis - forgotten contributors to the pathophysiology?.
Bateman, Grant A., Lechner-Scott, Jeannette, Lea, Rodney A.. BioMed Central; 2016. A comparison between the pathophysiology of multiple sclerosis and normal pressure hydrocephalus: is pulse wave encephalopathy a component of MS?.
Kister, Ilya, Spelman, Tim, Iuliano, Gerardo, Hupperts, Raymond, Pucci, Eugenio, Trojano, Maria, Butzkueven, Helmut, , Alroughani, Raed, Lechner-Scott, Jeannette, Duquette, Pierre, Grand'Maison, Francois, Slee, Mark, Lugaresi, Alessandra, Barnett, Michael, Grammond, Pierre. B M J Group; 2016. Discontinuing disease-modifying therapy in MS after a prolonged relapse-free period: a propensity score-matched study.
Jokubaitis, Vilija G., Spelman, Tim, Lechner-Scott, Jeannette, Barnett, Michael, Shaw, Cameron, Vucic, Steve, Liew, Danny, Butzkueven, Helmut, Slee, Mark, Australian MSBase Study Group. Public Library of Science; 2013. The Australian Multiple Sclerosis (MS) Immunotherapy Study: a prospective, multicentre study of drug utilisation using the MSBase platform.
Broadley, Simon A., Barnett, Michael H., Marriott, Mark, Mason, Deborah F., Parratt, John, Reddel, Stephen W., Shaw, Cameron P., Slee, Mark, Spies, Judith, Taylor, Bruce V., Carroll, William M., Kilpatrick, Trevor J., Boggild, Mike, King, John, McCombe, Pamela A., Pollard, John D., Willoughby, Ernest, Brew, Bruce J., Butzkueven, Helmut, Heard, Robert, Hodgkinson, Suzanne, Kermode, Allan G., Lechner-Scott, Jeannette, Macdonell, Richard A. L.. Elsevier; 2014. Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 3 Treatment practicalities and recommendations.
Schofield, Peter W., Lechner-Scott, Jeannette, Loughland, Carmel, Moore, Tammie. Nova Science Publishers; 2013. The Audio Recorded Cognitive Screen (ARCS): a flexible and versatile instrument for clinic or research.
Malhotra, Sunny, Rio, Jordi, Lechner-Scott, Jeannette, Drulovic, Jelena, Chan, Andrew, Martinelli-Boneschi, Filippo, García-Merino, Antonio, Montalban, Xavier, Comabella, Manuel, Urcelay, Elena, Nurtdinov, Ramil, Bustamante, Marta F., Fernández, Oscar, Oliver, Begoña, Zettl, Uwe, Brassat, David, Killestein, Joep. Oxford University Press; 2015. NLRP3 inflammasome is associated with the response to IFN-β in patients with multiple sclerosis.
Shahijanian, Fernando, Parnell, Grant P., Baxter, Alan, Kermode, Allan, Carroll, William, Butzkueven, Helmut, Booth, David, Stewart, Graeme, Vucic, Steve, Wiley, James, Field, Judith, Tajouri, Lotti, McKay, Fiona C., Griffiths, Lyn, Barnett, Michael, Scott, Rodney, Lechner-Scott, Jeannette, Moscato, Pablo, Broadley, Simon, Slee, Mark, Kilpatrick, Trevor, Taylor, Bruce, Charlesworth, Jac, Gatt, Prudence N., Brown, Matt, Mason, Deborah, Stewart, Graeme J., Booth, David R., Shojoei, Maryam, O'Connor, Kate S., Schibeci, Stephen D., Brilot, Fabienne, Liddle, Christopher, Batten, Marcel. Oxford University Press; 2014. The CYP27B1 variant associated with an increased risk of autoimmune disease is underexpressed in tolerizing dendritic cells.
Beecham, Ashley H., Patsopoulos, Nikolaos A., Oturai, Annette, Saarela, Janna, Fontaine, Bertrand, Hemmer, Bernhard, Martin, Claes, Zipp, Frauke, D'Alfonso, Sandra, Martinelli-Boneschi, Filippo, Taylor, Bruce, Harbo, Hanne F., Xifara, Dionysia K., Lechner-Scott, Jeannette, Davis, Mary F., Kemppinen, Anu, Cotsapas, Chris, Shah, Tejas S., Spencer, Chris, Booth, David, Goris, An. Nature Publishing Group; 2013. Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis.
MacDonell, Richard, Nagels, Guy, Wang, Ping, Yeh, Michael, Hovenden, Maria, Soelberg Sørensen, Per, Laplaud, David-Axel, Pozzilli, Carlo, de Jong, Brigit, Martins da Silva, Ana, Nicholas, Richard, Lechner-Scott, Jeannette, Gaebler, Julia A., Agarwal, Sonalee. Sage; 2016. Improved patient-reported health impact of multiple sclerosis: the ENABLE study of PR-fampridine.
Spelman, Tim, Gray, Orla, Boz, Cavit, Verheul, Freek, Oreja-Guevara, Celia, Barnett, Michael, Grand'Maison, Francois, Rio, Maria Edite, Lechner-Scott, Jeannette, Van Pesch, Vincent, Bolanos, Ricardo Fernandez, Flechter, Shlomo, Trojano, Maria, Braber-Moerland, Leontien Den, Iuliano, Gerardo, Amato, Maria Pia, Slee, Mark, Cristiano, Edgardo, Saladino, Maria Laura, Paine, Mark, Vella, Norbert, Kasa, Krisztian, Deri, N, Petersen, Thor, Herbert, Joseph, Moore, Fraser, Petkovska-Boskova, Tatjana, Alroughani, Raed, Savino, Aldo, Shaw, Cameron, Vucic, Steve, Santiago, Vetere, Bacile, Elizabeth Alejandra, Skromne, Eli, Izquierdo, Guillermo, Poehlau, Dieter, Cabrera-Gomez, Jose Antonio, Lucas, Robyn, Butzkueven, Helmut, Lugaresi, Alessandra, Hupperts, Raymond, Bergamaschi, Roberto, Duquette, Pierre, Giuliani, Giorgio. John Wiley and Sons; 2014. Seasonal variation of relapse rate in multiple sclerosis is latitude dependent.
Binder, Michele D., Fox, Andrew D., Laverick, Louise, Foo, Grace, Fabis-Pedrini, Marzena J., Spelman, Timothy, Jordan, Margaret A., Baxter, Alan G., Foote, Simon, , , , Merlo, Daniel, , , , , , , , , , Lechner-Scott, Jeannette, Johnson, Laura J., , , , , , Moscato, Pablo, Scott, Rodney, , , , Giuffrida, Sarah E., , Calvert, Rainer, Akkermann, Rainer, Ma, Gerry Z. M., Perera, Ashwyn A., Gresle, Melissa M.. Public Library of Science (PLoS); 2016. Common and low frequency variants in MERTK are independently associated with multiple sclerosis susceptibility with discordant association dependent upon HLA-DRB1*15:01 status.
Spelman, Timothy, Kalincik, Tomas, Grand-Maison, Francois, Izquierdo, Guillermo, Grammond, Pierre, Duquette, Pierre, Lugaresi, Alessandra, Lechner-Scott, Jeannette, Oreja-Guevara, Celia, Hupperts, Raymond, Petersen, Thor, Barnett, Michael, Zhang, Annie, Trojano, Maria, Butzkueven, Helmut, , Pellegrini, Fabio, Wiendl, Heinz, Kappos, Ludwig, Tsvetkova, Larisa, Belachew, Shibeshih, Hyde, Robert, Verheul, Freek. John Wiley & Sons; 2015. Comparative efficacy of switching to natalizumab in active multiple sclerosis.
Kalincik, Tomas, Jokubaitis, Vilja, Duquette, Pierre, Grammond, Pierre, Solaro, Claudio, Grand'Maison, Francois, Hupperts, Raymond, Prevost, Julie, Sola, Patrizia, Ferraro, Diana, Terzi, Murat, Butler, Ernest, Spelman, Tim, Slee, Mark, Kermode, Allan, Fabis-Pedrini, Marzena, McCombe, Pamela, Barnett, Michael, Shaw, Cameron, Hodgkinson, Suzanne, Butzkueven, Helmut, MSBase Study Group,, Horakova, Dana, Havrdova, Eva, Trojano, Maria, Lechner-Scott, Jeannette, Lugaresi, Alessandra, Prat, Alexandre, Girard, Marc. Sage; 2018. Cladribine versus fingolimod, natalizumab and interferon β for multiple sclerosis.
Al-iedani, Oun, Arm, Jameen, Ribbons, Karen, Lea, Rodney L., Lechner-Scott, Jeannette, Ramadan, Saadallah. Elsevier; 2018. Diurnal stability and long-term repeatability of neurometabolites using single voxel 1H magnetic resonance spectroscopy.